Skip to content

ATEC

Alphatec Holdings, Inc.

NASDAQ · USHealthcareMedical - Devices
$8.27-3.10%

Price as of Jul 20, 2026

ATEC growth

Alphatec Holdings, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+22.5%
EBITDA
+97.4%
EBIT
+58.8%
EPS
+27.8%
Free cash flow
+108.6%
Operating cash flow
+558.2%

Forward estimates

Revenue
+21.7%
EBITDA
EPS
+137.1%

Three-year CAGR

Revenue
+29.6%
EBITDA
+26.3%
EBIT
+39.7%
Net income
+11.6%
EPS
+15.0%
Free cash flow
+102.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.